The FDA approved of a gene therapy called Zolgensma that was developed by a team of researchers at the University of Pennsylvania to correct the genes that cause spinal muscle atrophy (SMA). SMA is caused by a mutation of a specific gene, SMN1, that affects nerve cells in the spinal cord. Zolgensma is a one-time […]
About Sydney Stressman
Sydney manages Select’s Twitter and LinkedIn accounts, writes the monthly newsletter Momentum and the biweekly Investor and Partner updates, manages Select’s website, and assists with any additional marketing responsibilities.
Entries by Sydney Stressman
Philadelphia-based ExpressCells closed on its first series A funding in July. The genetic engineering company received $800,000 to build the commercial and operational infrastructure to sell its knock-in cell lines. “This will allow us to market our novel plasmid technology that will give scientists better cell models for drug discovery and other research purposes,” said […]
Regional life sciences industry leaders shared their top reasons for choosing to operate in Greater Philadelphia at the Greater Philadelphia Life Sciences and Innovation Showcase in June. Bradley Campbell, president and chief operating officer of Amicus Therapeutics explained that his company now operates in Greater Philadelphia because it is where the first FDA-approved gene and […]
Roche Holding AG has agreed to purchase Spark Therapeutics Inc for $4.3 billion. Spark, which was founded by the Children’s Hospital of Philadelphia, will continue to operate in Philadelphia as an independence company under Roche. “With its worldwide reach and extensive resources, Roche will help us accelerate the development of more gene therapies for more […]
The California-based Iovance Biotherapeutic is expanding to the Philadelphia Navy Yard in South Philadelphia to build a 136,000 square foot office, lab, and production facility. “We know there are certainly trained employees in the region who have worked in cell therapy and have deep roots in cell therapy,” said Maria Fardis, the president and chief […]
The 2019 BIO International Convention attracted approximately 19,000 biotech professionals and companies throughout the world to Philadelphia. A number of regional life science industry leaders and potential prospecting companies united at the Greater Philadelphia Life Sciences and Innovation Showcase to speak about the biotech advancements happening here in our region. Speakers included: Dan Hilferty, CEO of Independence […]
Years prior, Boston was notoriously known as the global hub for life sciences, but recently Greater Philadelphia has become a life sciences hotspot with more space and talent. Developers in Greater Philadelphia are experiencing a demand for office and lab space as life sciences companies move to the region. The founder and CEO of University […]
Century Therapeutics LLC, a Philadelphia-based biotech startup, received $250 million in venture financing to continue developing cellular therapy treatments for cancer. “I am grateful to have their experience to guide the development of our promising allogeneic cell therapies for cancers,” said one of Century’s co-founders, Osvaldo “Lalo” Flores. Article by the Philadelphia Inquirer
The University of the Sciences graduate students will be able to receive a Master of Business Administration (MBA) degree with a specialization in the cannabis industry starting this fall. While there are other universities in the country that offer courses on marijuana, this program will be the first-of-its-kind to focus on the commerce of cannabis, […]
Two Greater Philadelphia companies were ranked on Fortune and Great Place to Work’s list of the “Best Large Workplaces for Millennials 2019.” To be considered, companies must have more than 50 millennial employees who were asked to respond to 60 survey questions. Comcast NBCUniversal, the Philadelphia-based global media and technology company, ranked 16 spots higher […]
Select Greater Philadelphia (Select) is the business attraction organization for northern Delaware, southern New Jersey, and southeastern Pennsylvania. A non-profit entity, Select highlights Greater Philadelphia’s unique business assets to national and global audiences with the ultimate goal of growing the economic vibrancy of our collective community through attracting new businesses and new jobs to our 11-county region. Select assists companies interested in locating in Greater Philadelphia by providing resources, detailed information, and connections.